GLI1-mediated pulmonary artery smooth muscle cell pyroptosis contributes to hypoxia-induced pulmonary hypertension

Author:

He Siyu12,Ma Cui13,Zhang Lixin13,Bai June12,Wang Xiaoying2,Zheng Xiaodong4,Zhang Junting12,Xin Wei12,Li Yiying12,Jiang Yuan12,Wang Sen3,Zhu Daling1256

Affiliation:

1. Central Laboratory of Harbin Medical University (Daqing), Daqing, People’s Republic of China

2. College of Pharmacy, Harbin Medical University, Harbin, People’s Republic of China

3. College of Medical Laboratory Science and Technology, Harbin Medical University (Daqing), Daqing, People’s Republic of China

4. Department of Genetics and Cell Biology, Harbin Medical University (Daqing), Daqing, People’s Republic of China

5. State Province Key Laboratories of Biomedicine-Pharmaceutics of China, Daqing, People’s Republic of China

6. Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, Harbin Medical University, Harbin, People’s Republic of China

Abstract

Pulmonary hypertension (PH) is a clinically common malignant cardiovascular disease. Pyroptosis is a new form of inflammatory cell death that is involved in many disease processes. Glioma-associated oncogene family zinc finger 1 (GLI1) is a transcriptional activator that participates in many diseases, but its role has never been explored in inducing pyroptosis and the progress of PH. In this study, we used an animal model and cell molecular biology to determine the effect of GLI1 on chronic hypoxia-mediated PH progression and pulmonary artery smooth muscle cell (PASMC) pyroptosis. The major findings of the present study are as follows: Hypoxia induced aberrant expression of GLI1. The inhibition of GLI1 attenuated hypoxia-induced PH and PASMC pyroptosis. Meanwhile, GLI1 enhanced apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) expression by binding with its promoter. GLI1 may promote PASMC pyroptosis through ASC to affect the progression of PH. These findings may identify novel targets for molecular therapy of PH.

Funder

National Natural Science Foundation of China

Excellent Young Talents Fund Program of Higher Education Institutions of Heilongjiang Province

Postdoctoral Research Funding of Heilongjiang Province

Returned Overseas Students Funding of Heilongjiang Province

the Fundamental Research Funds for the Provincial Universities

Publisher

American Physiological Society

Subject

Cell Biology,Physiology (medical),Pulmonary and Respiratory Medicine,Physiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3